NCT00914901Unknown4 期
Blood and Urinary Concentrations of Inhaled Salmeterol in Asthmatic Subjects and Elite Athletes With Asthma.
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Serum and urine concentrations of salmeterol
研究概览
简要总结
The purpose of the study is to assess the blood and urine concentrations of inhaled salmeterol.
详细描述
The purpose of the study is to assess the serum and urine concentrations of salmeterol after inhalation of 100 microgram salmeterol in one dose.
Furthermore, to evaluate any difference in three groups: 10 healthy men, 10 male asthmatic subjects and 10 male elite athletes with asthma.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Physician-diagnosed asthma with positive reversibility or challenge test.
- •Informed consent.
- •Age between 18-45 years.
- •Sex: male.
- •Asthma classified as mild to moderate according to GINA guidelines.
- •Used beta-2-agonist in minimum 12 months.
排除标准
- •Smokers or ex-smokers with a smoking history of 10 pack years or more.
- •Respiratory tract infections within the last 2 weeks prior to study day.
- •Subjects with other chronic diseases than asthma and/or allergy.
- •Allergy towards the study medicine.
- •Use of beta-2-agonist 10 days prior to study day.
研究组 & 干预措施
Healthy
Other
10 healthy men
干预措施: inhaled salmeterol (Drug)
Asthmatics
Other
10 male asthmatic subjects
干预措施: inhaled salmeterol (Drug)
Elite athletes with asthma
Other
10 male elite athletes with asthma
干预措施: inhaled salmeterol (Drug)
结局指标
主要结局
Serum and urine concentrations of salmeterol
时间窗: baseline, 4, 8, and 12 hours after medicine administration
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Urinary Concentration After SalmeterolHealthyNCT06657547University of Copenhagen24
已完成
4 期
Pharmacological Properties of SalmeterolPharmacokinetics in Healthy Young MenNCT02558088University of Copenhagen11
进行中（未招募）
1 期
Blood- and urinary concentrations of inhaled salmeterol in asthmatic subjects and elite athletes with asthma.The purpose of this study is to assess the serum and urine concentrations of inhaled salmeterol and evaluate the difference in three groups: healthy men, male asthmatic subjects and male elite athletes with asthma.MedDRA version: 9.1Level: LLTClassification code 10003553Term: AsthmaEUCTR2009-012069-70-DKBispebjerg Hospital, Respiratory and Allergy Research Unit30
Unknown
4 期
Concentrations of Formoterol in Blood and UrineAsthmaNCT00914654Bispebjerg Hospital30
已完成
4 期
Diagnosis et Treatment of Asthma in Athlete : Boundary Between Disease and DopingAsthmaNCT02655328University Hospital, Toulouse14